StreetAlpha.app
Home › Stocks › TNXP

Tonix Pharmaceuticals Holding Corp. (TNXP)

Healthcare
Members
LATEST PRICE

Tonix Pharmaceuticals develops and sells prescription medicines for fibromyalgia and acute migraine. TNXP reports earnings on Mon, Nov 9, 2026.

Prices, price targets and earnings estimates for TNXP are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is TNXP in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 9
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated TNXP in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for TNXPThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
Canaccord GenuityInitiated
Oct 26Buy
Raymond JamesInitiated
Jun 25Buy
TD CowenInitiated
May 4Buy
DateFirmActionRatingPrice target
Oct 26Canaccord GenuityInitiatedBuy
Jun 25Raymond JamesInitiatedBuy
May 4TD CowenInitiatedBuy
Loading…

Whale Options Flow

90D

No whale options trades in TNXP in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TNXP is in one of them and how their past TNXP trades turned out.

See how it works→ View all auto pilots→
TNXP in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TNXP in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About Tonix Pharmaceuticals Holding

Tonix Pharmaceuticals is a biopharmaceutical company based in Berkeley Heights, New Jersey. It sells TONMYA, a sublingual medicine for fibromyalgia in adults that is designed for bedtime use, along with two prescription sumatriptan products for acute migraine. Its main customers are prescribers in rheumatology, primary care, pain management and neurology practices, reached through national wholesalers and specialty distributors. The company also develops treatments for central nervous system disorders, immunology, infectious diseases and rare diseases.

Headquarters
Berkeley Heights, NJ
Summary based on the company’s 2026 annual report (10-K) ↗